Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients

CompletedOBSERVATIONAL
Enrollment

207

Participants

Timeline

Start Date

March 19, 2020

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions
Ovarian Neoplasms
Trial Locations (20)

Unknown

Research Site, Matsuyama

Research Site, Tōon

Research Site, Yoshida

Research Site, Kitakyushu

Research Site, Sapporo

Research Site, Amagasaki

Research Site, Kobe

Research Site, Tsukuba

Research Site, Sendai

Research Site, Kashihara

Research Site, Izumo

Research Site, Bunkyo

Research Site, Minato

Research Site, Musashino

Research Site, Shinjuku

Research Site, Fukushima

Research Site, Gifu

Research Site, Kumamoto

Research Site, Niigata

Research Site, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY